Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
ROY STEIGBIGEL, State University of New York at Stony Brook
JOHN W. MELLORS, University of Pittsburgh
REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
Raltegravir doubled the antiviral response rate and the …
Raltegravir doubled the antiviral response rate and the …